News

Deal Announcements

Ignyta Garners $6 Million Venture Capital Funding

Wednesday, January 2, 2013 5:38:00 AM PDT | VentureDeal
   San Diego, California  --  Biotechnology company Ignyta has secured $6 million in its second round of venture capital funding.

Ignyta is developing technology that improves the quality of biomarkers and tests available to rheumatologists and their patients.

City Hill Ventures, Colt Ventures and others invested in the round.

The company said it would use the proceeds to begin clinical studies related to its molecular-based assay for diagnosing rheumatoid arthritis.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1